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Bo Xu,1 and Haoyan Wang1,3
Abstract—Cigarette smoke (CS) increases the risk of chronic obstructive pulmonary disease (COPD) by
causing inflammation, emphysema, and reduced lung function. Additionally, CS can induce autophagy
which contributes to COPD.Arachidonic acid-derived epoxyeicosatrienoic acids (EETs) have promising
anti-inflammatory properties that may protect the heart and liver by regulating autophagy. For this
reason, the effect of decreased soluble epoxide hydrolase (sEH, Ephx2)-mediated EET hydrolysis on
inflammation, emphysema, lung function, and autophagy was here studied in CS-inducedCOPD in vivo.
Adult male wild-type (WT) C57BL/6J and Ephx2−/− mice were exposed to air or CS for 12 weeks, and
lung inflammatory responses, air space enlargement (emphysema), lung function, and autophagy were
assessed. Lungs of Ephx2−/− mice had a less pronounced inflammatory response and less autophagy
with mild distal airspace enlargement accompanied by restored lung function and steady weight gain.
These findings support the idea that Ephx2 may hold promise as a therapeutic target for COPD induced
by CS, and it may be protective property by inhibiting autophagy.
KEYWORDS: Ephx2; epoxyeicosatrienoic acids; inflammation; autophagy; cigarette smoke.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is an
inflammatory disease characterized by emphysema, persis-
tent airflow limitations, and reduced lung function [31]. It
is the third leading cause of death worldwide and it repre-
sents an important public health challenge [44]. Cigarette
smoking (CS) is the main risk factor for developing COPD
and airway inflammation, which contributes to airway
remodeling and pulmonary emphysema [42].
Chronic exposure to CS leads to lung inflammation
and increased levels of macrophages [37], neutrophils [8,
16], and dendritic cells (DCs) [40]. An uncontrolled and
prolonged inflammatory response may destroy lung tissue
and promote remodeling [5, 36]. Elimination of inflamma-
tion is a key treatment target for COPD.
Epoxyeicosatrienoic acids (EETs), arachidonic acid-
derived epoxides, are important regulators of inflammation
and vascular homeostasis [6]. Manipulating themmay be a
suitably anti-inflammatory pharmacological strategy. No-
tably, arachidonic acid is metabolized by CYP
epoxygenase enzymes, CYP2C and CYP2J subfamilies,
to biologically active EETs [46]. Then EETs are hydro-
lyzed by soluble epoxide hydrolase (sEH, Ephx2) to
dihydroxyeicosatrienoic acid (DHETs), which have less
biological function [46]. EETs are found in numerous
organs such as the lung, kidney, heart, liver, and brain
[12, 47]. They have anti-inflammatory effects on human
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bronchi [23]. A sEH inhibitor has been found to attenuate
CS-induced inflammation in mouse models as well [32].
Nording and colleagues showed TNF-αmRNA expression
to be significantly decreased in animals treated with a sEH
inhibitor and in Ephx2−/− animals in response to sub-
chronic tobacco smoke (TS) exposure [30]. Previous stud-
ies have suggested that EETs disrupt NF-κB signaling to
exert anti-inflammatory effects [9, 29]. However, the phe-
notypic influence of Ephx2 disruption on inflammation in
response to chronic CS is unclear.
Autophagy is a dynamic process involving cytoplas-
mic organelle and protein turnover via a lysosome-
associated degradation pathway. Material is engulfed by
autophagosomes and then fuses with lysosomes to be
degraded by lysosomal hydrolases. Starvation, oxidative
stress, cytokines, and xenobiotics can induce autophagy,
suggesting it is important for maintaining cellular homeo-
stasis and adapting to adverse environments [13, 17, 18].
Autophagy contributes to lung disease, exerting effects on
fundamental cellular processes such as inflammation, apo-
ptosis, redox balance, and proliferation [21, 26, 27]. COPD
patients have more autophagy in epithelial cells than in
healthy individuals [25–27] and previous studies have
suggested that autophagy contributes to inflammation and
emphysema in COPD [1, 3, 4]. López-Vicario and
Samokhvalov reported that EETs modulate autophagic
response and inhibit inflammation in fatty livers of obese
subjects and improved starved cardiac cell viability and
recovery [19, 35]. However, the effect of EETs or de-
creased soluble epoxide hydrolase (sEH, Ephx2)-mediated
EET hydrolysis on autophagy in CS-induced COPD is less
well understood. For this reason, we here investigated
whether Ephx2 deficiency could modulate inflammation
and autophagy in COPD and influences emphysema and
lung function using Ephx2 (sEH) knockout (Ephx2−/−)




Ephx2−/− mice were a gift from the Yi Zhu
Laboratory (Tian Jin Medical University, Tian Jing,
China). Mice were backcrossed with C57BL/6J mice
for five generations prior to use to produce heterozy-
gous Ephx2+/− offspring. Ephx2+/− offspring was
intercrossed to generate Ephx2+/+ and Ephx2−/− mice.
All animals were housed in a temperature- and
humidity-controlled room and kept on a 12:12-h
light/dark cycle. Clean food and water were given ad
libitum. Tail snips were obtained for DNA extraction to
identify murine genotype with PCR. Primers were as
follows: F1: 5′-TGG CAC GAC CCT AAT CTT AGG
TTC-3′; R1: 5′-TGC ACG CTG GCA TTT TAA CAC
CAG-3′; R2: 5′-CCA ATG ACA AGA CGC TGG
GCG-3′ [39]. Primer F1/R1 predicts a 338-base pair
(bp) amplicon and indicates the Ephx2+/+, primer F1/
R2 predicts a 295-bp product and it indicates Ephx2−/−
[39]. Primers were designed by TIANGEN Biotech
(Beijing) Co., Ltd and genotypic analysis was exam-
ined on 3% agarose gel (Lonza Rockland, Inc.,
Rockland, ME, USA). All animal studies were ap-
proved by the Animal Care and Use Committee of
Capital Medical University.
Animal CS Exposure
WT and Ephx2−/− mice (10 to 12 weeks old, ∼18–
20 g) were randomly divided into two groups (N = 10).WT
controls and KO controls were exposed to filtered air. WT-
CS and KO-CS groups were whole-body exposed to CS
from ten cigarettes (11 mg tar, 0.8 mg nicotine/cigarette;
Daqianmen, China) in a sealed 50-L metal exposure cham-
ber. Mice were exposed to 10 cigarettes for 60 min per
exposure, once daily for 12 weeks. During exposure,
smoke was maintained between 80 and 100 ppm at 18%
oxygen. Animal weight was measured once every 2 weeks.
Preparation of BALF and Cell Counts
After 12 weeks CS exposure, mice were sacrificed
and bronchoalveolar lavage fluid (BALF) was obtained by
cannulating the trachea and lavaging it three times with
0.5 ml of 0.9% sodium chloride. BALF cells were centri-
fuged with PBS at 1000×g for 10min at 4 °C. Supernatants
were collected and stored at −80 °C to measure inflamma-
tory factors. Pelleted BALF cells were resuspended in 1 ml
PBS, and erythrocytes, neutrophils, and monocytes were
quantified with a LH 750 (Beckman Coulter, Miami, FL,
USA).
Cytokine Analysis
TNF-α and IL-1β in BALF were measured with
ELISA using mouse TNF-α and IL-1β ELISA MAX™
Deluxe (BioLegend, San Diego, CA, USA) according to
manufacturer’s instructions. Each sample was assayed in
triplicate.
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Lung Histology and Quantification of Emphysema
After mice were sacrificed, their tracheas and lungs
were removed and inflated with 4% paraformaldehyde at a
pressure of 25 cm H2O. Tissues were embedded in paraf-
fin, and 5-μm-thick sections were stained with hematoxy-
lin and eosin (H&E). Alveolar size was quantified using
the mean linear intercept (Lm) of the airspace which is a
measurement of airspace enlargement (emphysema). Lm
was measured in 10 randomly selected fields of tissue
sections observed at a magnification of ×200.
Lung Function
Lung functionwas assessedwith a ventilator for small
animals (flexiVent™; SCIREQ, Montreal, QC, Canada).
After 12 weeks of daily exposure to air or CS, mice were
anesthetized with thiopental (250 mg/kg, ip, Sigma-
Aldrich, St. Louis, MO, USA) and tracheostomized. Then,
a 20G angiocatheter (BD Insyte, Sandy, UT, USA) was
inserted into the trachea and a catheter was used to connect
the angiocatheter and the ventilator. The tidal volume of
the ventilator was set at 10 ml/kg, and respiratory rate was
120 breaths/min with a positive end-expiratory pressure of
3 cm H2O. Lung function was expressed as Newtonian
resistance (Rn), respiratory system resistance (Rrs), respi-
ratory system compliance (Crs), and respiratory system
elasticity (Ers).
Immunohistochemistry
Lungswere removed and fixed in 4%paraformaldehyde
overnight and then embedded in paraffin to obtain three
consecutive 5-μm thick sections. Sections were de-
paraffinized in xylene and rehydrated through graded alcohol,
followed by rinsing in PBS. Sections were placed in EDTA-
antigen retrieval buffer and then exposed to 3% H2O2 for
10 min to block endogenous peroxidase activity at room
temperature. Samples were blocked with sheep serum for
15 min and incubated in LC3B, Beclin 1, and NFκB primary
antibodies (Cell Signaling, Beverly, MA, USA) diluted in
blocking sera (1:200) at 4 °C overnight. After incubation,
slides were washed three times and incubated with biotinyl-
ated secondary antibodies (Cell Signaling, Beverly, MA,
USA). A hen enzyme reaction was performed using peroxi-
dase substrate and sections were counterstained with hema-
toxylin and dehydrated through graded alcohol,mountedwith
neutral gum and observed under an inverted phase contrast
microscope (LeicaDMI3000 B; Leica, Solms, Germany) at
×400 magnification. The immunostaining intensity assess-
ment was performed using Image-Pro Plus 6.0 software.
Mean integrated optical density (IOD) was used to express
the antigen spot color intensity. The nuclear NF-κB staining
was performed by counting staining nucleus. Each group
contained three sections from different mice.
Electron Microscopy
Lung tissues were fixed in 2.5% glutaraldehyde for
2 h and washed three times in PBS for 10 min at room
temperature. Subsequently, tissues were post-fixed in 2%
osmium tetroxide and washed three times in double-
distilled H2O. Then tissue was dehydrated in a series of
graded ethanol followed by embedding in agar 100 resin.
Seventy nanometer sections were cut and post stained with
uranyl acetate and lead citrate. Tissues were photographed
with a FEI Morgagni 268D transmission electron micro-
scope (FEI, Eindhoven, Netherlands) at 80 kV. Images
were acquired using an 11 megapixel Morada charge-
coupled device camera (Morada; Olympus). At least three
different lungs per group at ×100,000 magnification were
used to assess autophagosomes.
Western Blot
Lung tissue was homogenized in ice-cold RIPA lysate
buffer (Applygen Technologies Inc., Beijing, China) accord-
ing to the manufacturer’s instructions. This was followed by
centrifugation at 15,000×g for 15min at 4 °C. Nuclear protein
was extracted with extraction reagents (Applygen Technolo-
gies Inc.) and protein was quantified with the BCA method
(Applygen Technologies Inc.). Samples (20 μg protein/lane)
were separated using 10% SDS-PAGE and then transferred
onto PVDF membranes. Membranes were blocked with 5%
nonfat milk for 2 h at room temperature and then washed
three times in TBST and incubated overnight with rabbit
polyclonal antibody against Beclin 1, NFκB (1:1000 dilution,
Cell Signaling Technology), β-actin (1:2000 dilution, Cell
Signaling Technology), and Lamin B1 (Abcam, Cambridge,
MA, USA) at 4 °C overnight. After three washes, membranes
were incubated with goat antibody linked to horseradish
peroxidase (Cell Signaling, Beverly, MA, USA) for 1 h, and
antibody-antigen reactivity was measured with Western blot
(Clinx Science Instruments Co., Ltd, China). Band density
was quantified with ImageJ software.
STATISTICS
Data were expressed as means ± SD. Statistical anal-
ysis was performed with SPSS 17.0 (SPSS Inc., Chicago,
IL, USA). Differences between two groups were assessed
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with a Student’s t test. Post hoc pairwise multiple compar-
isons were performed using one-way ANOVA followed by
a Bonferroni correction (significance was set at P < 0.05).
RESULTS
Ephx2−/− Mice Have Fewer Weight Changes After CS
Exposure
WT and KO mouse weight was significantly reduced
after 12 weeks of cigarette smoke exposure compared to
those exposed to air (Fig. 1b). KO mice gained weight
more slowly than the WT group in both exposure groups
(Fig. 1c). After 12 weeks of cigarette smoke exposure,
smoking KO animals weighed less than those in the WT
group (Fig. 1b). However, after 12 weeks of treatment,
fold-change difference between KO-Con and KO-CS
groups was less than that between WT-Con and WT-CS
groups (Fig. 1d). It may be that the stable weight observed
in Ephx2−/− mice is protective against cigarette smoke
exposure.
Ephx2−/−Mice Have Less Airway Resistance in Response
to CS Exposure
Rn and Rrs of lung function were significantly in-
creased after CS exposure in bothWTand Ephx2−/− groups
(Fig. 2a, b). Also, Rn and Rrs indices in CS-Ephx2−/−mice
were lower than those of CS-WT mice (Fig. 2a, b). These
Fig. 1. Weight ofWTand KOmice changes after exposure to cigarette smoke. a Representative genotype analysis ofWTand Ephx2−/−mice.WT type mice
produced a gene 338 bp in size and Ephx2−/−mice produced a gene product 295 bp in size. b–dWTmice (n = 20) and Ephx2−/−mice (n = 20) were exposed
to air (air-WT, n = 10; air-Ephx2−/−, n = 10) or CS (CS-WT, n = 10; CS-Ephx2−/−, n = 10) for 12 weeks and weight was measured once every 2 weeks. b
Weight gain over time. WTweight increased more than in the KO group. cAfter 12 weeks of treatment, mean weight of mice in the CS-WT group was lower
than in the air-WT group and the mean weight of mice in the CS-Ephx2−/− group was lower than that of mice in the air-Ephx2−/−group. d After 12 weeks of
treatment, the Ephx2−/− group weight fold-change was less than that of theWT group. Results are expressed as means ± SD. #P < 0.05, significant differences
betweenCS-exposed group and its corresponding air-exposed group; ##P < 0.01, significant differences between CS-exposed group and its corresponding air-
exposed group; *P < 0.05, significant differences between CS-exposedWTmice and CS-exposed Ephx2−/−mice, **P < 0.01, significant differences between
CS-exposed WT mice and CS-exposed Ephx2−/− mice.
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data suggest that lungs of Ephx2−/− mice are less
susceptible to CS-induced airway resistance. However,
Crs and Ers did not differ in the air-exposed and CS-
exposed groups (Fig. 2c, d), perhaps due to insufficient
CS exposure time to cause change in Crs and Ers.
Ephx2−/−Mice ShowAttenuated Emphysema in Response
to CS
Pulmonary emphysema is a clinical phenotype of
COPD, characterized by irreversible enlargement of air-
spaces distal to the terminal bronchiole and irreversible
loss of alveolar structures [41]. Lm was measured to quan-
tify emphysema and CS-exposed WT and CS-exposed
Ephx2−/− mice had greater alveolar size compared with
corresponding air-exposed mice. Lm of CS-exposed
Ephx2−/− mice was significantly lower compared with
CS-exposed WT mice (Fig. 3), indicating a partial protec-
tion against pulmonary emphysema.
Ephx2−/− Mice Have Less Inflammation in Response to
CS
Inflammatory factors, IL-1β, and TNF-α were
measured in BALF and these factors were greater
after 12 weeks of CS exposure both in WT and
Ephx2−/− mice compared with air-exposed mice
(Fig. 4a–c). CS-exposed Ephx2−/− mice had less
inflammatory cell influx compared with CS-exposed
WT mice and CS-exposed WT, and Ephx2−/− mice
had more TNF-α and IL-1β in BALF than the air-
exposed WT and Ephx2−/− mice (Fig. 4d, e). CS-
exposed Ephx2−/− mice had less TNF-α and IL-1β
compared with CS-exposed WT mice (Fig. 4d, e).
Fig. 2. Ephx2−/−mice have less airway resistance in response to CS exposure. a Rn; b Rrs; c Crs; and d Ers were measured in air- and CS-exposedWTand
Ephx2−/− mice, as described. a, b Rn and Rrs increased after 12 weeks of CS exposure in both groups. Rn and Rrs were significantly lower in CS-exposed
Ephx2−/−mice. c, dCrs and Ers did not differ between groups with CS exposure. Data are means ± SD (n = 3–4mice/group). #P < 0.05, significant difference
from corresponding air-exposed mice; ##P < 0.01, significant difference from corresponding air-exposed mice; ###P < 0.001, significant difference from
corresponding air-exposed mice. *P < 0.05, significant difference between CS-exposed WT mice and CS-exposed Ephx2−/− mice.
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Thus, inflammation is aggravated after 12 weeks of
CS exposure and Ephx2−/− mice are protected against
this to a degree.
Ephx2−/− Mice Have Reduced NF-κB Expression in Re-
sponse to CS
NF-κB was measured and was observed to be
greater in CS-exposed WT mice and CS-exposed
Ephx2− /− mice compared to air-exposed mice
(Fig. 5a, b). Ephx2−/− mice had reduced NF-κB ex-
pression compared to WT mice in response to CS
(Fig. 5a, b). Immunohistochemical data were consis-
tent with blot data (Fig. 5c, d) and blot and immu-
nohistochemistry results were consistent with findings
of greater inflammatory factors and cells in BALF
(Fig. 4). Thus, Ephx2 deficiency may increase resis-
tance to inflammation via the NF-κB pathway.
Fig. 3. There is less air space enlargement in Ephx2−/−mice in response to CS. aRepresentative H&E stained lung sections exposed to air and CS inWTand
Ephx2−/− mice. b Lm was calculated. Original magnification, ×100. Results are expressed as means ± SD (n = 3 mice/group). ##P < 0.01, significant
difference from corresponding air-exposed mice; ###P < 0.001, significant difference from corresponding air-exposed mice. *P < 0.05, significant difference
between CS-exposed WT mice and CS-exposed Ephx2−/−mice.
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Ephx2−/− Mice Have Reduced Autophagy in Response to
CS
Autophagy contributes to COPD [3] and may
interact with EETs [19, 35]. For this reason,
autophagy was measured in each mouse group
(Fig. 6a). Data show that autophagosomes increased
in CS-exposed WT and CS-exposed Ephx2−/− mice
compared to air-exposed animals. CS-exposed
Ephx2−/− mice had fewer autophagosomes than CS-
Fig. 4. Ephx2−/− mice had reduced inflammation in response to CS. After 12 weeks of exposure to air or CS, BALF were obtained and inflammatory cells
and TNF-α and IL-1β were quantified. a–c CS-exposed WT mice and CS-exposed Ephx2−/− mice had more leukocytes, neutrophils, and monocytes in
BALF than air-exposed mice. CS-exposed Ephx2−/−mice had significantly fewer inflammatory cells in BALF. d, e TNF-α and IL-1βwere increased in CS-
exposedWTand CS-exposed Ephx2−/−mice than with air-exposed WT and air-exposed Ephx2−/−mice. CS-exposed Ephx2−/−mice had significantly lower
TNF-α and IL-1β than CS-exposedWTmice. Results are expressed as means ± SD (n = 4 mice/group). #P < 0.05, significant difference from corresponding
air-exposed mice; ##P < 0.01, significant difference from corresponding air-exposed mice; ###P < 0.001, significant difference from corresponding air-
exposed mice; *P < 0.05, significant difference between CS-exposed WT mice and CS-exposed Ephx2−/− mice.
503Ephx2-Deficiency Inhibits CS-Inflammation and Autophagy
Fig. 5. Nuclear factor NF-κB is expressed in the lungs in response to CS. NF-κB expressionwas measured after 12 weeks of exposure to air or CS. aWestern
blot for NF-κB expression in lung tissue. b Relative intensity of NF-κB calculated by densitometry. Results represent means ± SD from at least three
independent experiments. c NF-κB expression in lung alveolar/airway epithelial cells from each group via immunohistochemistry (n = 3 mice/group).
Inverted phase contrast microscopy revealing dark brown staining representing NF-κB expression (×400). dGraph is IntDen of NF-κB. #P < 0.05, significant
difference from corresponding air-exposed mice; ##P < 0.01, significant difference from corresponding air-exposed mice; ###P < 0.001, significant difference
from corresponding air-exposed mice; *P < 0.05, significant difference between CS-exposed WT mice and CS-exposed Ephx2−/− mice; **P < 0.01,
significant difference between CS-exposed WT mice and CS-exposed Ephx2−/− mice.
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exposed WT mice (Fig. 6a, b). In this way, CS can
induce autophagy in a COPD mouse model and
Ephx2− /− mice may be less suscept ib l e to
autophagy. Data also show that Beclin 1 and LC3B
Fig. 6. Ephx2−/−mice had less autophagy in response to CS-WTand Ephx2−/−mice were exposed to air or CS for 12weeks and autophagy protein LC3B and
Beclin 1 expression was measured. a Autophagosomes under electron microscopy (×100,000); white arrows depict autophagosomes (n = 3 mice/group). b
EM images scored autophagosomes. Data are expressed as AVs/100 μm2 (N = 10 images representative of each group). cWestern blot of Beclin 1. dRelative
intensity of Beclin 1 was calculated by densitometry and values are presented as means ± SD. e–h Representative immunohistochemical images for Beclin 1
(e) and LC3B (g) in mouse lung tissues (n = 3 mice/group). f, h Graph represents IntDen of Beclin 1 and LC3B and values are presented as means ± SD.
#P < 0.05, significant difference from corresponding air-exposed mice; ##P < 0.01, significant difference from corresponding air-exposed mice. *P < 0.05,
significant difference between CS-exposed WT mice and CS-exposed Ephx2−/− mice.
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(Fig. 6c, e, g) were significantly higher in CS-
exposed WT and CS-exposed Ephx2−/− mice than in
air-exposed mice and that CS-exposed Ephx2−/− mice
had less Beclin 1 and LC3B expression compared to
CS-exposed WT.
DISCUSSION
COPD is mainly caused by cigarette smoking, and it is
characterized by emphysema, pulmonary inflammation,
fibrogenesis, and reduced lung function [31]. Increased
Fig. 6. (continued)
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autophagy is also observed in lungs of mice exposed to
chronic CS [3]. The greatest amount of airway inflammation
was observed in mice after 12 weeks of CS exposure, and
WT and Ephx2−/− mice both had aggravated emphysema,
increased airway resistance, and inflammation and
autophagy compared to air-exposed animals, but Ephx2−/−
mice had fewer of these symptoms than WT mice and they
had reduced autophagy. In this way, Ephx2 deficiency may
protect individuals from CS-induced lung disease.
CYP-mediated arachidonic acid metabolism is an
important regulator of inflammation and EETs, whose
CYP epoxygenase-derived products are proposed to be
anti-inflammatory mediators in vascular, liver, and renal
diseases [29]. EETs are hydrolyzed by sEH, which is
encoded by Ephx2−/− gene [28], to DHETs, which has a
less important biological function. Inhibitors targeting
sEH-induced increasing endogenous EETs can be antihy-
pertensive and anti-inflammatory as well as protective to
the brain, heart, and kidneys [11, 24]. Recently, EETs and
sEH inhibitors have been shown to have an anti-
inflammatory effect in lung disease. Morin’s group report-
ed that 14, 15-EET has anti-inflammatory effects on human
bronchi treated with TNF-α [23]. Ma and colleagues re-
ported that 11, 12-EET and 14, 15-EET can reduce CS
extraction-induced release of IL-8 in human bronchial
epithelial cells [20]. Podolin’s group demonstrated that a
sEH inhibitor reduces CS-induced pulmonary inflamma-
tion by inhibiting its initiation and promoting its resolution
Fig. 6. (continued)
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[32]. Recently, an initial report indicated that inhibition of
sEH downregulates the inflammatory response induced by
acute or sub-chronic tobacco smoke exposure, which was
consistent with data from Ephx2−/− knockout mice [30].
This was the first report to describe chronic CS-induced
inflammatory response in an Ephx2−/− knockout mice
model. Current data showed that 12 weeks of CS
exposure elevated inflammatory cells in BALF of WT
and Ephx2−/− mice but that, Ephx2−/− mice had less
inflammatory cell influx than WT mice. TNF-α and IL-
1β displayed the same trend. NF-κB expression was noted
to be elevated in CS-exposed WT and Ephx2−/− mice, and
Ephx2−/− mice had less NF-κB than WT mice. Immuno-
histochemistry and blot data were consistent with these
findings.
EETs are reported to inhibit the NF-κB signaling
pathway, and subsequently inhibit expression of vascular
cell adhesion molecule-1 (VCAM-1), attenuating leuko-
cyte migration [29]. Nording’s group reported that 8, 9-
EET/DHET and 14, 15-EET/DHET ratios in plasma were
more elevated in Ephx2−/− mice subjected to after acute
and sub-chronic CS exposure than inWTmice, suggesting
an anti-inflammatory property of Ephx2 deficiency [30]. In
this way, Ephx2 deficiency may lead to increased
EETs/DHET ratios which may block the NF-κB signaling
pathway and protect against chronic CS-induced lung in-
flammation. The manner by which this occurs is uncertain.
In this way, Ephx2−/− mice are less susceptible to CS-
induced emphysema and airway resistance and air space
enlargement is greater in WT and Ephx2−/− mice in
response to CS exposure but comparatively less in CS-
exposed Ephx2−/− mice. Pulmonary emphysema occurs in
COPD and is characterized by irreversible enlargement of
airspaces distal to the terminal bronchiole and irreversible loss
of alveolar structures [41]. Previous reports have suggested
that infiltration of neutrophils and macrophages with release
of proteolytic enzymes in response to CS contributes to lung
tissue destruction in mouse emphysema models [7, 10, 38].
Apoptosis triggered by oxidative stress can also contribute to
pathogenesis of CS-induced emphysema [14].
Ephx2−/− mice have reduced inflammation and
EETs have a role in an anti-apoptotic CS-induced hu-
man bronchial epithelial cell line. In this way, the
mechanism of repair of tissue in Ephx2−/− mice with
emphysema may depend on EET properties. COPD
features elevation of respiratory resistance and
reduced compliance [2, 43]. Yang’s group reported
that respiratory system resistance indices were
elevated after 10 or 12 months of tobacco inhalation
[45]. This is consistent with the current observations.
After 12 weeks of CS exposure, Rn and Rrs increased
in both exposed animal groups even though Ephx2−/−
mice had normal Rn and Rrs levels and WT mice did
not. This may be partly due to the lower concentrations
of fewer inflammatory cells and inflammatory factors.
There was no significant difference between the CS-
exposed group and the air-exposed group with respect
to Crs or Ers likely because 12 weeks is not sufficient
for these to change appreciably. Ephx2−/− mice gained
less weight than WT but why this is so is unclear.
Ephx2 deficiency inhibits autophagy in a CS-
exposed COPD mouse model. Data showed there to
be more autophagosomes in lung tissues of CS-
exposed WT mice and CS-exposed Ephx2−/− mice
than in animals exposed to air, and CS-exposed
Ephx2−/− mice had fewer autophagosomes than WT
mice. In this way, autophagy was enhanced in a
COPD mouse model and Ephx2 deficiency inhibited
autophagy. Beclin 1 and LC3B data are consistent with
these trends. Chen’s group reported for the first time
that increased autophagy is associated with CS-induced
COPD [3], and autophagy was induced in the current
COPD model. An and colleagues reported that TLR4
exerts a protective role in CS-induced emphysema
development by reducing the autophagic pathway [1].
Ji’s group reported that Vam3 decreases CS-induced
autophagy and inhibits oxidative stress. Stefan and
colleagues proposed that autophagy has an effect on
the stress response to CS exposure in vitro and may
contribute to the etiology of COPD [34]. Two reports
have described EETs and heart and liver protection via
autophagy regulation [19, 35]. In this way, Ephx2−/−
mice may have protection against CS-induced lung
inflammation and this likely takes place through re-
duced autophagy but EETs and autophagy interactions
require elucidation to confirm these assertions. In ad-
dition to the protective role of autophagy suppression
we proved, autophagy is a double-edge sword and it
has a complex cross-talk with apoptosis [33]. Autoph-
agy primarily plays a protective role that may prevent
cell death and it has been demonstrated that autophagy
plays a critical role in maintaining cellular homeostasis
and the adaption to environmental stress (oxidative
stress, starvation, hypoxia, etc.) [13–15, 22]. However,
it has been proved that both excessive and impaired
autophagy can cause cell death in some model systems
due to the interaction with apoptosis [33]. Deficiency
of LC3B and Beclin 1 inhibits cell death induced by
CSE in pulmonary epithelial cells and the airspace
enlargement and apoptosis after cigarette smoke
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exposure are inhibited in LC3B-deficient mice [3, 4,
14]. Further studies are required to elucidate the role of
autophagy in COPD. In conclusion, we used mouse
model with a deficiency in Ephx2 to explore the effect of
this gene on chronic CS-induced COPD. Mice lacking this
gene had less lung inflammation and reduced emphysema
and airway resistance. Also, the genemay contribute to less
autophagy. In this way, this may represent a novel thera-
peutic target for the treatment of COPD.
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